Diana Harshbarger: “We have heard a lot about PBMs today, and how they operate in the shadows.”

Congress should bring transparency, competition, and accountability to this process so providers, innovators, and patients all benefit from a more open and competitive system.

As a pharmacist, I've seen insurance companies find every excuse in the book to avoid paying for the care patients actually need. My TRUTH in Coverage Act restores fairness, promotes transparency and ensures patients aren't left paying the…

The 340B program was created with good intentions to help vulnerable and underserved patients access care, but unfortunately, it has evolved into a massive, poorly supervised program with weak transparency and accountability safeguards.

As a lifelong pharmacist, I’ve seen firsthand how PBMs game the system. When the same corporate giant that sets reimbursement rates also owns the pharmacy collecting them, that’s not a free market—it’s a rigged one.